XZG-16132-77730

1 vaccination 10 coded responses 14 check-ins 10 free-text entries 4 call cases

Sex: Female
Age at first dose: 56-60
ZIP prefix: 234 / VA
Registered: 2021-03-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Dose 1 — Pfizer-BioNTech
2021-03-06
Registered in v-safe
2021-03-06
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-07
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea, Pruritus — Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-08
Survey response — days 1–6 daily, dose 1
MedDRA: Pruritus — Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to work

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection site

Adult check-in
2021-03-11
Survey response — 7 day, dose 1
MedDRA: Dyspnoea, Pruritus, Rash — Feeling: Good · Joint pains, Muscle or body aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-18
Health check-in — 14 day, dose 1
Feeling: Good

Adult check-in
2021-03-26
Survey response — 21 day, dose 1
MedDRA: Immunisation reaction, Medical counselling, Pruritus, Respiratory tract oedema, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-26
Report sent to call center — 21 day, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-01
Survey response — 28 day, dose 1
MedDRA: Fatigue, Pruritus — Feeling: Fair · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-08
Survey response — 35 day, dose 1
MedDRA: Bone pain, Fatigue, Lip swelling, Pruritus, Respiratory disorder, Self-medication, Swelling face — Feeling: Poor · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-16
Survey response — 42 day, dose 1
MedDRA: Pruritus, Rash, Self-medication — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-04-16
Report sent to call center — 42 day, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-03
Survey response — 3 month, dose 1
MedDRA: Dyspnoea, Inhalation therapy — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-06-03
Report sent to call center — 3 month, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-18
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-09-02
Survey response — 6 month, dose 1
MedDRA: Dyspnoea, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2021-09,2024-11 · check-in answers available
2021-09-02
Report sent to call center — 6 month, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-03
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2022-03-04
Health check-in — 12 month, dose 1
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-03-26	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-04-16	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-06-03	Successful 2021-06-18	Reported to VAERS voluntarily prior to GDIT contact
2021-09-02	Successful 2021-09-03	Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 5

Systemic reaction (other): Mild short of breath

Systemic reaction (other): Itchy face lips nose hips at times hard to take a deep breath

Systemic reaction (other): Itchy face hips .

Systemic reaction (other): Facial rash itching mild sob

Release 6

Symptoms: Itching.facial and across hips ,legs,arms. This comes and goes in varying degrees since respiratory swelling reaction to psizer vaccine.Doc said no to second one

Healthcare visit (other): Call doc.i am rn over 35+ yrs ,will see doc in a month

Symptoms: Fatigue, full body itching despite hydration, no new products in diet, environment,contact, intermittent rash continues face ,arms since first dose of psizer vaccine 3/4.

Release 7

Symptoms: Fatigue achy bones skin itches everywhere despite antihistamine hypoallergenic body cleanser and moisturizer. Since respiratory reaction with facial and kip swelling to mrna first vaccine 3/4 no #2 scheduled

Symptoms: Full body itching. Intermittent flat pink diffuse rash. Unilateral. No triggers, patterns identified. Treated with benadryl, loratadine,pecid and hydroxyzine.

Release 8

Symptoms: Increased sob. Require daily Albuterol nebulizer every am. Steroid+ labs inhaler Bid and Saba prn inhaler to carry with me. Continue anthistamines famatodine bid , benadryl,and montelukast,flonase

Release 9

Symptoms: Worsening breathing

Healthcare visit (other): Pcp

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	✓	·	✓
HCVO	Office visit	✓	·	✓
HCVO	Unevaluable event	○	✓	○
SD	Bone pain	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Hypersensitivity	○	·	○
SD	Immunisation reaction	✓	·	✓
SD	Inhalation therapy	✓	✓	✓
SD	Lip swelling	✓	✓	✓
SD	Medical counselling	✓	·	✓
SD	Pruritus	✓	✓	✓
SD	Rash	✓	✓	✓
SD	Respiratory disorder	✓	✓	✓
SD	Respiratory tract oedema	✓	·	✓
SD	Self-medication	✓	✓	✓
SD	Swelling face	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Pruritus	✓	✓	✓
SRO	Rash	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release